Low dose tocilizumab for mitigation of cytokine release syndrome with bispecific antibodies in relapsed/refractory multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Issam Hamadeh, Maximillian Merz, Andriy Derkach, Tala Shekarkhand, Alexander Lesokhin, Sham Mailankody, Malin Hultcrantz, Carlyn Tan, Hani Hassoun, Urvi Shah, Kylee Maclachlan, Sridevi Rajeeve, Hamza Hashmi, Francesco Maura, Ross Firestone, Alice Wang, Dhwani Patel, Michael Scordo, Gunjan Shah, Heather Landau, Sergio Giralt, Saad Usmani, Neha Korde
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417007166